Canada markets open in 1 hour 57 minutes

Lixte Biotechnology Holdings, Inc. (LIXT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.7900-0.1600 (-5.42%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
898.1
898.1
1,349
1,737
1,224
Selling General and Administrative
4,192
4,192
4,962
4,984
2,043
Total Operating Expenses
5,090
5,090
6,311
6,720
3,266
Operating Income or Loss
-5,090
-5,090
-6,311
-6,720
-3,266
Interest Expense
16.233
16.233
8.875
7.414
3.674
Total Other Income/Expenses Net
1.954
1.954
-3.374
-1.163
0.89
Income Before Tax
-5,087
-5,087
-6,313
-6,728
-3,265
Income from Continuing Operations
-5,087
-5,087
-6,313
-6,728
-3,265
Net Income
-5,087
-5,087
-6,313
-6,728
-3,265
Net Income available to common shareholders
-5,087
-5,087
-6,313
-6,728
-3,265
Basic EPS
-3.24
-2.66
-3.99
-5.00
-2.90
Diluted EPS
-3.24
-2.66
-3.99
-5.00
-2.90
Basic Average Shares
1,769
1,916
1,582
1,347
1,128
Diluted Average Shares
1,769
1,916
1,582
1,347
1,128